000 01334 a2200397 4500
005 20250514210620.0
264 0 _c20041209
008 200412s 0 0 eng d
022 _a0091-6749
024 7 _a10.1016/j.jaci.2004.08.042
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSilkoff, Philip E
245 0 0 _aThe Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cNov 2004
300 _a1241-56 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAsthma
_xdiagnosis
650 0 4 _aBreath Tests
650 0 4 _aChild
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNitric Oxide
_xanalysis
650 0 4 _aReference Values
700 1 _aCarlson, Mats
700 1 _aBourke, Trevor
700 1 _aKatial, Rohit
700 1 _aOgren, Elisabeth
700 1 _aSzefler, Stanley J
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 114
_gno. 5
_gp. 1241-56
856 4 0 _uhttps://doi.org/10.1016/j.jaci.2004.08.042
_zAvailable from publisher's website
999 _c15223761
_d15223761